Elastrin Therapeutics Inc.

It´s been such a great conference last week at the #RejuvenationSummit by @4ever_healthy! linkedin.com/feed/update/ur…

Join us today at #RESI, as one of the #therapeutics finalists (Wednesday 21, 2 - 2:50pm). Our CEO is also one of the speakers at the #Entrepreneur Workshop, Wednesday 21 from 11 - 11:50 am. Join our pitch, and come by our pitch company poster at Easel #48! #RESIBoston

Great panel discussion yesterday at @MassBio Patient Advocacy Summit!

30 startups have been selected as semifinalists for the NEXT Venture Summit. Ten of the 30 semi-finalists were SCRA Companies. These companies represent a broad cross-section of industries and are among the most venture-ready startups in the region.

Meet our newest #teammember and Senior R&D Manager, Sonia Golombek. She is such a great addition to our team and will help bringing our #technology to market! linkedin.com/feed/update/ur…

Congratulations to SCBIO investors & #lifescience startup companies @elastrin and @ZyloTherapies who have been selected as semifinalists for the NEXT Venture Summit! ow.ly/E0ab50KunJI @NEXTupstateSC#sclifesciences #biotech #startup

Congratulations to RESI Boston Innovator’s Pitch Challenge finalist, @elastrin! CEO, Matthias Breugelmans, will pitch to a panel of #investors September 21-22. Join RESI to cheer on our IPC finalists:

Do you know what #orphandiseases are? Head over to our blog and read an insight and outlook. #raredisease #elastinrepair #regenerativemedicine elastrin.com/post/an-insigh…

Cardiologists predict a serious rise in CVD rates by 2060. Fortunately, SCBIO investor, @elastrin is taking action. Their nanotechnology will help restore elastic tissue, reversing damage to the CV System. ow.ly/SSi050KeNip #sclifesciences #biotech #cardiovascular

We will be at DxPx Conference at AACC in Chicago! Contact Matthias or book your meeting here: lnkd.in/eKXpiWP8 to discover more about our #technology. He is also one of the speakers at #RejuvenationStartupSummit, don´t miss out this opportunity to meet our team. #LONGEVITY

@Kizoo Looking forward to the #rejuventionStartupSummit 2022 in Berlin. Amazing speakers!

Dr. Alexander Schueller, CEO of CellVieto speak at the #RejuvenationStartupSummit 2022. Also meet Scientific Co-Founders Prof. Dr. James McCully and Dr. Sitaram Emani. Cellvie is a Harvard spin-off pioneering Therapeutic Mitochondria Transfer. forever-healthy.org/news/dr-alexan…

Watch Douglas Mulhall, one of Elastrin Therapeutics founders, talk about #epigenetics and how our researchers are developing a new way to reverse heart disease damage in arteries (from the series Local News LIVE) via this link -> lnkd.in/ejXX92CP #biotech #rejuvenation

@elastrin, an SC Launch Inc Portfolio Company, announced the closing of its $10 million funding round, led by @Kizoo, Starbloom Capital, and SC Launch Inc. Congrats @elastrin! 👏👏👏 Read the full press release: lnkd.in/dNp6AynF

#startup #funding ~#EpiWatch closes #financing round, appoints new Directors ~#HealthTehc #startup @aroggaofficial raises $1.3M in #SeedFunding ~@Kizoo portfolio company @elastrin closes $10M #funding round

@SCRAInnovation @Kizoo Thanks for your support @SCRAInnovation :)

@Kizoo Thank you @Kizoo, we are very blessed to have your support and are excited to get our therapy to patients!

Proud to lead this $10M round at Elastrin to boost the development of therapeutics that render calcified tissue and organs supple again and start clinical trials in humans in 2023. kizoo.com/news/kizoo-por…

Proud to announce the closing of our $10 Million #fundinground, led again by @Kizoo, completed by SC Launch Inc and Starbloom Capital. Thanks to all our investors, supporters and our whole team! Read more: elastrin.com/post/kizoo-por…

We are very excited for today´s 1st SAB meeting in London with our well-experienced #scientific advisory #boardmembers (elastrin.com/advboard). #science #regenerative #Health

@alliancerm Very interesting report!

Our 2021 Annual Report, released today, gives a comprehensive overview of the #cellandgenetherapy space, incl. a never-before-released deep dive into the oncology space, prevalent vs. #raredisease, an update on #geneediting, #genetherapy delivery, & more: alliancerm.org/sector-report/…